Seroatlas · Human Serome Atlas

CLCN7

H(+)/Cl(-) exchange transporter 7

Also known as: CLC-7, CLC7, CLCN7_HUMAN, OPTA2, PPP1R63

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P51798
Gene
CLCN7
Ensembl
ENSG00000103249
Chromosome
16
Canonical length
805 aa
Protein class
Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters

OverviewNCBI Gene

The product of this gene belongs to the CLC chloride channel family of proteins. Chloride channels play important roles in the plasma membrane and in intracellular organelles. This gene encodes chloride channel 7. Defects in this gene are the cause of osteopetrosis autosomal recessive type 4 (OPTB4), also called infantile malignant osteopetrosis type 2 as well as the cause of autosomal dominant osteopetrosis type 2 (OPTA2), also called autosomal dominant Albers-Schonberg disease or marble disease autosoml dominant. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. OPTA2 is the most common form of osteopetrosis, occurring in adolescence or adulthood. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

805 residues, UniProt reviewed canonical sequence.

>P51798|CLCN7
     1  MANVSKKVSW SGRDRDDEEA APLLRRTARP GGGTPLLNGA GPGAARQSPR SALFRVGHMS
    61  SVELDDELLD PDMDPPHPFP KEIPHNEKLL SLKYESLDYD NSENQLFLEE ERRINHTAFR
   121  TVEIKRWVIC ALIGILTGLV ACFIDIVVEN LAGLKYRVIK GNIDKFTEKG GLSFSLLLWA
   181  TLNAAFVLVG SVIVAFIEPV AAGSGIPQIK CFLNGVKIPH VVRLKTLVIK VSGVILSVVG
   241  GLAVGKEGPM IHSGSVIAAG ISQGRSTSLK RDFKIFEYFR RDTEKRDFVS AGAAAGVSAA
   301  FGAPVGGVLF SLEEGASFWN QFLTWRIFFA SMISTFTLNF VLSIYHGNMW DLSSPGLINF
   361  GRFDSEKMAY TIHEIPVFIA MGVVGGVLGA VFNALNYWLT MFRIRYIHRP CLQVIEAVLV
   421  AAVTATVAFV LIYSSRDCQP LQGGSMSYPL QLFCADGEYN SMAAAFFNTP EKSVVSLFHD
   481  PPGSYNPLTL GLFTLVYFFL ACWTYGLTVS AGVFIPSLLI GAAWGRLFGI SLSYLTGAAI
   541  WADPGKYALM GAAAQLGGIV RMTLSLTVIM MEATSNVTYG FPIMLVLMTA KIVGDVFIEG
   601  LYDMHIQLQS VPFLHWEAPV TSHSLTAREV MSTPVTCLRR REKVGVIVDV LSDTASNHNG
   661  FPVVEHADDT QPARLQGLIL RSQLIVLLKH KVFVERSNLG LVQRRLRLKD FRDAYPRFPP
   721  IQSIHVSQDE RECTMDLSEF MNPSPYTVPQ EASLPRVFKL FRALGLRHLV VVDNRNQVVG
   781  LVTRKDLARY RLGKRGLEEL SLAQT

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CLCN7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
10
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
37 nTPM

Expression across tissuesHPA

Tissue

  • adrenal gland: 37 nTPM
  • bone marrow: 28 nTPM
  • skeletal muscle: 28 nTPM
  • spleen: 27 nTPM
  • cerebellum: 24 nTPM
  • thyroid gland: 23 nTPM

Single-cell type

  • melanocytes: 112 nCPM
  • retinal horizontal cells: 70 nCPM
  • hofbauer cells: 57 nCPM
  • proximal tubule cells: 56 nCPM
  • retinal amacrine cells: 54 nCPM
  • monocytes: 49 nCPM

Immune cell

  • non-classical monocyte: 3.4 nTPM
  • intermediate monocyte: 2.4 nTPM
  • classical monocyte: 1.5 nTPM
  • myeloid DC: 1.2 nTPM
  • plasmacytoid DC: 1.1 nTPM
  • eosinophil: 1 nTPM

Brain region

  • pons: 54 nTPM
  • midbrain: 52 nTPM
  • choroid plexus: 51 nTPM
  • thalamus: 46 nTPM
  • medulla oblongata: 46 nTPM
  • cerebral cortex: 44 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CLCN7.

Disease | AllUniProt

Conditions CLCN7 is implicated in, by any mechanism.

Disease | GeneticClinVar

95 pathogenic / likely-pathogenic of 1,464 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.39
gnomAD pLI
0.27
gnomAD missense Z
2.11
DepMap mean gene effect
0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CLCN7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CLCN7 as an antibody target. Whether an autoantibody or antibody against CLCN7 could matter depends on whether native CLCN7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CLCN7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CLCN7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CLCN7. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...